Active ingredientPicotamide MonohydrateCat. No. P-P107-001CAS 80530-63-8Family · Pharmaceutical analytical standards
Picotamide
An antiplatelet drug approved in Italy for arterial thrombosis and peripheral artery disease: it acts twice on thromboxane A2, blocking both its production and its receptor on platelets. This family brings together the active ingredient and pharmacopoeial impurities.
Did you know?In 2004 the DAVID study evaluated it in 1,209 people with type 2 diabetes and peripheral artery disease, followed for about two years.
Go to the active ingredient →Active ingredientPicotamide MonohydrateCat. No. P-P107-001CAS 80530-63-8
Pharmacopoeial impurityPicotamide EP Impurity ACat. No. P-P107-002CAS 2206-43-1No product matches your search.
EDQM standards 2
The official European Pharmacopoeia standards for this family.
ImpurityPicotamide impurity A CRSEDQM code P1645005Family PicotamideReference substancePicotamide monohydrate CRSEDQM code P1645000Family PicotamideNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.